Pharming Group N.V. - ADR
PHAR
Get informed when a big investor buys or sells
+ FollowMarket Cap$917.42M
Close$
$15.35
23.1% upside
Current Fair Value
23.1% upsideUndervalued by 23.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $917.42 Million |
|---|---|
| Enterprise Value | $980.52 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.04 |
| Beta | 0.12 |
| Outstanding Shares | 70,140,400 |
Return
| Return on Equity | 4.27% |
|---|---|
| Return on Assets | 2.35% |
| Return on Invested Capital | 1653.73% |
Valuation & Multiples
| P/E Ratio | 80.02 |
|---|---|
| PEG | -124.15 |
| Price to Sales | 2.49 |
| Price to Book Ratio | 4.16 |
| Enterprise Value to Revenue | 2.76 |
| Enterprise Value to EBIT | 0.16 |
| Enterprise Value to Net Income | 85 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.43 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$0.05
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$0.06
Average shareholder expectationRevenue Estimate
$101.28 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.12%▼ 0.09% |
|---|---|
| Total Invested | $1.38M▼ 44.47% |
| Investors Holding | 11▲ 1.00% |
ESG Score
No data
About Pharming Group N.V.
CEO: Sijmen de Vries